Publication | Open Access
Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance
23
Citations
38
References
2013
Year
We identified a promising pyrazolo[1,5-a]pyrimidine compound devoid of ABC transporter interaction, highly suitable for further preclinical and clinical evaluation for the treatment of cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1